Skip to main content
Beta
Checking market hours
MarketsLoading authentic market snapshot...

BIO — Bio-Rad Laboratories, Inc. Class A Common Stock

Unclassified · Common StockOpen Vantage View
Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search

BIOBio-Rad Laboratories, Inc. Class A Common Stock Live data

$388.59▲ +2.11 (0.6%)as of Nov 11, 2026, 6:08 PM UTC
Price chartUnavailable
Loading price history...

52-Week Range

Trailing twelve months

$236.73$396.23

1-Month Range

Month up 6.8%

$352.82$388.75

Daily Price Range

Day up 0.6%

$382.76$389.99

Volume

vs 246810 avg

59920246810 avg

Profile

Identity and capital structure

SectorUnclassified
IndustryCommon Stock
Market Cap$10.4B
Short % of Float—
Employees—
Sales$2,583M
Shares Outstanding21,832,130
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.bio.com
Bio-Rad Laboratories, Inc. Class A Common Stock — Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manu….· via yahoo

Warnings

1 signal

Live
  • No material red flags detected in fundamental screen

Scores

0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)

Value
74
Growth
63
Quality
76
Sentiment
95
Insider Sent.
—
Piotroski F
4
Altman Z
3.6
Consensus rating unavailable — no analyst coverage on file for BIO.
Price targets unavailable — no 12-month targets on file for BIO.
Valuation Engine

DCF Intrinsic Valuation Model

Run an interactive 5-year Discounted Cash Flow valuation on BIO, calculate Margin of Safety, and stress-test WACC discount hurdles.

Open DCF Workstation
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:08 PM UTC